59 reports of this reaction
3.4% of all PYRITHIONE ZINC reports
#3 most reported adverse reaction
RASH is the #3 most commonly reported adverse reaction for PYRITHIONE ZINC, manufactured by Wal-Mart Stores Inc. There are 59 FDA adverse event reports linking PYRITHIONE ZINC to RASH. This represents approximately 3.4% of all 1,712 adverse event reports for this drug.
Patients taking PYRITHIONE ZINC who experience rash should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RASH is moderately reported among PYRITHIONE ZINC users, representing a notable but not dominant share of adverse events.
In addition to rash, the following adverse reactions have been reported for PYRITHIONE ZINC:
The following drugs have also been linked to rash in FDA adverse event reports:
RASH has been reported as an adverse event in 59 FDA reports for PYRITHIONE ZINC. This does not prove causation, but indicates an association observed in post-market surveillance data.
RASH accounts for approximately 3.4% of all adverse event reports for PYRITHIONE ZINC, making it one of the most commonly reported side effect.
If you experience rash while taking PYRITHIONE ZINC, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.